Competitor Analysis: Ebola Virus Vaccines and Therapeutics

Competitor Analysis: Ebola Virus Vaccines and Therapeutics

The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections provides a competitor evaluation in the field of new molecules for prevention or treatment of Ebola virus infections as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of therapeutic antibodies, immunoglobulins, RNA, proteins, vaccines and small molecules for prevention and  treatment of Ebola virus infections. In addition, the report lists company-specific R&D pipelines of Ebola virus vaccines and therapeutics. Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.